BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/23/2021 6:43:04 AM | Browse: 222 | Download: 239
![](/Contents/images/gold_circle.png) |
Received |
|
2021-02-25 13:35 |
![](/Contents/images/gold_circle.png) |
Peer-Review Started |
|
2021-02-25 13:38 |
![](/Contents/images/gray_circle.png) |
To Make the First Decision |
|
|
![](/Contents/images/gold_circle.png) |
Return for Revision |
|
2021-05-07 20:27 |
![](/Contents/images/gold_circle.png) |
Revised |
|
2021-05-12 12:07 |
![](/Contents/images/gold_circle.png) |
Second Decision |
|
2021-08-06 03:17 |
![](/Contents/images/gray_circle.png) |
Accepted by Journal Editor-in-Chief |
|
|
![](/Contents/images/gold_circle.png) |
Accepted by Company Editor-in-Chief |
|
2021-08-06 06:56 |
![](/Contents/images/gold_circle.png) |
Articles in Press |
|
2021-08-06 06:56 |
![](/Contents/images/gray_circle.png) |
Publication Fee Transferred |
|
|
![](/Contents/images/gray_circle.png) |
Edit the Manuscript by Language Editor |
|
|
![](/Contents/images/gold_circle.png) |
Typeset the Manuscript |
|
2021-08-19 15:19 |
![](/Contents/images/gold_circle.png) |
Publish the Manuscript Online |
|
2021-08-23 06:43 |
ISSN |
2218-4333 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Minireviews |
Article Title |
Current challenges in applying gene-driven therapies in clinical lung cancer practice
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jatta Saarenheimo, Heidi Andersen, Natalja Eigeliene and Antti P Jekunen |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Jatta Saarenheimo, PhD, Research Scientist, Department of Pathology, Vasa Central Hospital, Hietalahdenkatu 2-4, Vaasa 65130, Finland. jatta.saarenheimo@vshp.fi |
Key Words |
Cancer drug; Availability; Gene testing; Tissue sampling; Lung cancer |
Core Tip |
Several gene-driven therapy drugs and molecular testing, together with immunohistochemistry, have evolved for lung cancer in recent years. Lung cancer is mutation dense and has more predictive genes that potentially influence treatment decisions than any other cancer type. In our case study, we ran into obstacles and delays in the diagnostic pathway both in tissue sampling and in gene testing. However, the major obstacle was the financial availability of new drugs. All elements need to be in place before a new drug can be given to patients, following the idea of the right drug at the right time. |
Publish Date |
2021-08-23 06:43 |
Citation |
Saarenheimo J, Andersen H, Eigeliene N, Jekunen AP. Current challenges in applying gene-driven therapies in clinical lung cancer practice. World J Clin Oncol 2021; 12(8): 656-663 |
URL |
https://www.wjgnet.com/2218-4333/full/v12/i8/656.htm |
DOI |
https://dx.doi.org/10.5306/wjco.v12.i8.656 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345